RABBI DSR

RABBI DSR product overview

RABBI DSR contains Rabeprazole 20 mg + Domperidone 30 mg in a sustained-release combination. It is listed in Positive Medicare’s Edinburgh division and gastro range. The composition is presented for pharmaceutical distributors, healthcare trade professionals and prospective franchise partners who need to verify the product before requesting current supply information.

Composition

• Rabeprazole 20 mg
• Domperidone 30 mg, sustained release

Availability and commercial enquiries

Contact Positive Medicare to ask about the current pack presentation, minimum order quantity, open franchise territory and commercial terms. Businesses can also explore the PCD pharma franchise programme or enquire about third-party pharmaceutical manufacturing services.

Important: This product information is intended for healthcare professionals and pharmaceutical business enquiries. It is not a substitute for medical advice. Prescription products should be used only as directed by a registered healthcare professional and in accordance with approved product labelling.